About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Beta Blockade in Critical Injury

NCT00356187·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Denver Health and Hospital Authority

With

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

ISS\>25, stable at 48 hours after injury
Fully resuscitated
Ventilated

You may not be if

Intracranial hypertension requiring active treatment
Hypotension/Pressors
Already on beta blocker for a standard indication

The record

StatusTerminated

PhasePhase 2

Taking part15

StartedFeb 2006

UpdatedMar 15, 2018

Conditions

Where1

Denver Health Medical Center
Denver, Colorado, United States

Clareo Health | Beta Blockade in Critical Injury